Combining an Hsp70 inhibitor with either an N- or C-terminal Hsp90 inhibitor produces mechanistically distinct phenotypes

被引:13
|
作者
Wang, Y. [1 ]
McAlpine, S. R. [1 ]
机构
[1] Univ New S Wales, Dept Chem, Sydney, NSW 2052, Australia
关键词
SHOCK-PROTEIN; 90; INDUCED APOPTOSIS; SMALL-MOLECULE; CANCER; SANSALVAMIDE; BINDING;
D O I
10.1039/c5ob00147a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Blocking the function of both heat shock protein 90 and 70 (Hsp90 and Hsp70) simultaneously limits these chaperones' cytoprotective effects on cancer cells. The unique phenotype associated with modulating Hsp90's C-terminus, when used in combination with Hsp70 inhibitors, produces a synergistic and highly relevant dual chemotherapy regimen.
引用
收藏
页码:3691 / 3698
页数:8
相关论文
共 50 条
  • [1] Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site
    Matts, Robert L.
    Dixit, Anshuman
    Peterson, Laura B.
    Sun, Liang
    Voruganti, Sudhakar
    Kalyanaraman, Palgunan
    Hartson, Steve D.
    Verkhivker, Gennady M.
    Blagg, Brian S. J.
    ACS CHEMICAL BIOLOGY, 2011, 6 (08) : 800 - 807
  • [2] N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes
    Wang, Y.
    McAlpine, S. R.
    CHEMICAL COMMUNICATIONS, 2015, 51 (08) : 1410 - 1413
  • [3] Contribution of N- and C-terminal domains to the function of Hsp90 in Saccharomyces cerevisiae
    Scheibel, T
    Weikl, T
    Rimerman, R
    Smith, D
    Lindquist, S
    Buchner, J
    MOLECULAR MICROBIOLOGY, 1999, 34 (04) : 701 - 713
  • [4] C-terminal sequences of hsp70 and hsp90 as non-specific anchors for tetratricopeptide repeat (TPR) proteins
    Ramsey, Andrew J.
    Russell, Lance C.
    Chinkers, Michael
    BIOCHEMICAL JOURNAL, 2009, 423 : 411 - 419
  • [5] C-terminal Hsp90 Inhibitor Targets Cancer Glycolysis and Fatty Acid Metabolism
    Subramanian, C.
    Zhu, J.
    Lubman, D.
    Blagg, B. S.
    Cohen, M. S.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S82 - S83
  • [6] A NOVEL C-TERMINAL HSP90 INHIBITOR WITH THERAPEUTIC EFFECT IN IMATINIB RESISTANT CML
    Bhatia, S.
    Deidrich, D.
    Stein, S.
    Lang, F.
    Ernst, T.
    Hochhaus, A.
    Borkhardt, A.
    Kurz, T.
    Gohlke, H.
    Hansen, F.
    Hauer, J.
    HAEMATOLOGICA, 2016, 101 : 233 - 233
  • [7] Coordination between N- and C-terminal Kinetics of Hsp90 Investigated by SmFRET
    Hugel, Thorsten
    Ratzke, Christoph
    Mickler, Moritz
    Hessling, Martin
    Buchner, Johannes
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 630A - 630A
  • [8] Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90
    Matokanovic, Mirela
    Barisic, Karmela
    Filipovic-Grcic, Jelena
    Maysinger, Dusica
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (01) : 149 - 158
  • [9] SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
    Lian, Bin
    Lin, Qian
    Tang, Wei
    Qi, Xin
    Li, Jing
    BIOMOLECULES & THERAPEUTICS, 2021, 29 (01) : 73 - 82
  • [10] Fungal mycotoxin penisuloxazin A, a novel C-terminal Hsp90 inhibitor and characteristics of its analogues on Hsp90 function related to binding sites
    Dai, Jiajia
    Zhu, Meilin
    Qi, Xin
    Wang, Yanjuan
    Li, Huilin
    Tang, Shuai
    Wang, Qiang
    Chen, Ao
    Liu, Ming
    Gu, Qianqun
    Li, Dehai
    Li, Jing
    BIOCHEMICAL PHARMACOLOGY, 2020, 182